<DOC>
	<DOCNO>NCT01667731</DOCNO>
	<brief_summary>This study evaluate efficacy , safety , tolerability sofosbuvir ( SOF ; GS-7977 ) plus ribavirin ( RBV ) adults chronic genotype 1 , 2 , 3 HCV infection coinfected HIV-1 .</brief_summary>
	<brief_title>Efficacy Safety Sofosbuvir Plus Ribavirin Chronic Genotype 1 , 2 3 Hepatitis C Virus ( HCV ) Human Immunodeficiency Virus ( HIV ) Co-infected Adults</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Sofosbuvir</mesh_term>
	<criteria>Willing able provide write informed consent Male female , age ≥ 18 year chronic HCV HIV1 infection HCV RNA &gt; 1 x 10^4 IU/mL screen Infection HCV genotype 1 , 2 3 determine screen HIV1 infection confirm positive ELISA Western blot screen Medical record must sufficient categorize interferon ( IFN ) eligibility prior treatment history PEG/RBV . Confirmation chronic HCV infection Ability determine presence/absence cirrhosis . HIV antiretroviral therapy ( ARV ) criteria one following : ARV untreated CD4 Tcell count &gt; 500 cells/mm^3 On stable , protocolapproved , ARV &gt; 8 week prior screen CD4 Tcell count &gt; 200 cells/mm^3 document undetectable plasma HIV1 RNA level ≥ 8 week precede screen visit Approved HIV antiretroviral medication base drug interaction study Not treat investigational drug device within 30 day screen visit Females confirm pregnant nursing nonchildbearing potential childbearing potential negative serum pregnancy test screening agree use protocol approve method birth control screen 6 month last dose RBV Males agree consistently correctly use condom female partner agree use protocol approve method birth control screen 7 month last dose RBV Must generally good health determine investigator . Liver image within 6 month baseline/Day 1 required cirrhotic patient , exclude hepatocellular carcinoma ( HCC ) Nongenotype 1/2/3 mixed genotype screen Genotype 1 prior treatment HCV Poor control ARV regimen Prior exposure directacting antiviral target HCV nonstructural protein ( NS ) 5B polymerase Chronic liver disease nonHCV etiology ( eg , hemochromatosis , Wilson 's disease , α1 antitrypsin deficiency , cholangitis ) A new AIDSdefining condition diagnose within 30 day prior screen Active , serious infection ( HIV HCV ) require parenteral antibiotic , antiviral antifungal within 30 day prior baseline Infection hepatitis B virus ( HBV ) Contraindication RBV therapy Chronic use systemically administer immunosuppressive agent ( eg , prednisone equivalent &gt; 10 mg/day ) History solid organ transplantation malignancy diagnose treat within 5 year Current prior history clinical hepatic decompensation significant gastrointestinal disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Hepatitis C</keyword>
	<keyword>Chronic</keyword>
	<keyword>HCV</keyword>
	<keyword>HIV</keyword>
	<keyword>Human Immunodeficiency Virus</keyword>
	<keyword>Co-Infected</keyword>
</DOC>